MedTrace Logo

Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer

NCT06649123 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6600

Last updated 2025-04-04

No results posted yet for this study

Summary

Development of a multiomics assay for use on OriColTM sampled rectal mucus for detection of cancer and significant polyps in symptomatic patients on the Colorectal Urgent Suspected Cancer pathway.

Conditions

Interventions

DIAGNOSTIC_TEST

Oricol Test

Assessment of diagnostic accuracy of Oricol Sampling device for triage in patients with suspected lower gastrointestinal cancer

Sponsors & Collaborators

  • Shrewsbury and Telford Hospitals NHS Trust

    collaborator OTHER

  • Origin Sciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2026-04-01
Completion
2027-04-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06649123 on ClinicalTrials.gov